CEACAM6 and pancreatic intraductal papillary-mucinous neoplasm: Seven key genes, namely, CEACAM1, CEACAM6, IL1RN, PLAUR, STAT1, TGFB1, and THBS2, offer clinicians potential biomarkers warranting further analysis for IPMN stratification and treatment targets for invasive PDAC.